Published in Eur J Clin Invest on December 01, 1996
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest (2003) 13.72
Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol (2002) 2.99
Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia. PLoS One (2013) 0.92
Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest (2014) 0.92
The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia. J Korean Med Sci (2007) 0.86
The responsiveness of isolated human hand vein endothelial cells in normal pregnancy and in pre-eclampsia. J Physiol (1998) 0.85
A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia. Am J Obstet Gynecol (2010) 0.85
Soluble flt-1 and the angiopoietins in the development and regulation of placental vasculature. J Anat (2002) 0.84
Pregnancy-induced hypertension and preeclampsia: levels of angiogenic factors in malaysian women. J Clin Biochem Nutr (2010) 0.83
Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates. Mediators Inflamm (2005) 0.82
Vascular endothelial growth factor +936C/T, -634G/C, -2578C/A, and -1154G/A polymorphisms with risk of preeclampsia: a meta-analysis. PLoS One (2013) 0.80
An unexpected tail of VEGF and PlGF in pre-eclampsia. Biochem Soc Trans (2011) 0.79
Serum levels of asymmetric dimethylarginine, vascular endothelial growth factor, and nitric oxide metabolite levels in preeclampsia patients. ISRN Obstet Gynecol (2013) 0.78
Assessment of Serum Vascular Endothelial Growth Factor Levels in Pregnancy-Induced Hypertension Patients. J Pregnancy (2017) 0.76
Endothelial dysfunction in the pathogenesis of pre-eclampsia in Ghanaian women. BMC Physiol (2017) 0.75
Expression levels of seven candidate genes in human peripheral blood mononuclear cells and their association with preeclampsia. Hypertens Pregnancy (2013) 0.75
POSTOPERATIVE NITROGEN LOSS AND STUDIES ON PARENTERAL NITROGEN NUTRITION BY MEANS OF CASEIN DIGEST. Ann Surg (1942) 6.94
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med (2001) 6.73
Hearing in the elderly: the Framingham cohort, 1983-1985. Part I. Basic audiometric test results. Ear Hear (1990) 2.71
Transthoracic Esophagogastrostomy for Carcinoma of the Middle Third of the Esophagus. Report of a Successful Resection. Ann Surg (1945) 2.53
Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst (1995) 2.44
Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta (2004) 2.29
A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod (1998) 2.12
Randomised controlled trial of educational package on management of menorrhagia in primary care: the Anglia menorrhagia education study. BMJ (1999) 1.96
Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta (2004) 1.74
Is computed tomographic grading of splenic injury useful in the nonsurgical management of blunt trauma? J Trauma (1994) 1.73
A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol (1998) 1.70
Effectiveness of adenoidectomy and tympanostomy tubes in the treatment of chronic otitis media with effusion. N Engl J Med (1987) 1.70
Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol (1999) 1.70
Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta (2008) 1.67
Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest (1996) 1.63
VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol (1996) 1.63
Traumatic rupture of the pericardium. Surgery (1983) 1.62
Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. Hum Reprod (1996) 1.58
Is genetic code redundancy related to retention of structural information in both DNA strands? Trends Biochem Sci (1990) 1.57
Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis. Hum Reprod (2004) 1.55
Chronic secretory otitis media: effects of surgical management. Ann Otol Rhinol Laryngol Suppl (1989) 1.53
Noonan syndrome with giant cell lesions. Int J Paediatr Dent (2005) 1.49
Normal human keratocyte density and corneal thickness measurement by using confocal microscopy in vivo. Invest Ophthalmol Vis Sci (2001) 1.47
Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod (1993) 1.45
Flexible docking using Tabu search and an empirical estimate of binding affinity. Proteins (1998) 1.45
Otologic complaints in temporomandibular joint syndrome. Arch Otolaryngol Head Neck Surg (1992) 1.38
Gynaecology--medical or surgical? BMJ (1996) 1.38
Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg (1995) 1.35
Survival following nonpenetrating traumatic rupture of cardiac chambers. Ann Thorac Surg (1987) 1.35
Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol (1981) 1.34
Regulation of vascular growth and function in the human placenta. Reproduction (2009) 1.33
Trends in hospitalization after injury: older women are displacing young men. Inj Prev (2003) 1.32
Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab (2001) 1.32
THE SIGNIFICANCE OF LIPOCAIC IN SURGERY. Ann Surg (1939) 1.26
Properties of large-conductance K+ channels in human myometrium during pregnancy and labour. Proc Biol Sci (1993) 1.26
New protocols for DNA sequencing with dye terminators. DNA Seq (1992) 1.25
Management of menorrhagia: an audit of practices in the Anglia menorrhagia education study. BMJ (2001) 1.23
Predictive value of tympanometry in middle ear effusion. Ann Otol Rhinol Laryngol (1986) 1.22
Blunt trauma to the carotid arteries. J Vasc Surg (1991) 1.22
Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil (1994) 1.22
Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Br J Obstet Gynaecol (1995) 1.22
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev (2000) 1.21
Use of a long acting somatostatin analogue in controlling life threatening ileostomy diarrhoea. Br Med J (Clin Res Ed) (1984) 1.21
Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod (1994) 1.20
Moose-motor vehicle collisions. An increasing hazard in northern New England. Arch Surg (1996) 1.20
Some characteristics of a population of mentally retarded young adults in a British city. A basis for estimating some service needs. J Ment Defic Res (1979) 1.20
Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer (2003) 1.18
Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil (1993) 1.18
Muscle growth in response to mechanical stimuli. Am J Physiol (1995) 1.18
Evaluation of the Pneumoslide latex agglutination test for identification of Streptococcus pneumoniae. J Clin Microbiol (1984) 1.17
Hypertonic saline resuscitation of patients with head injury: a prospective, randomized clinical trial. J Trauma (1998) 1.15
Pyridine nucleotide metabolism in Escherichia coli. 3. Biosynthesis from alternative precursors in vivo. J Biol Chem (1973) 1.14
Human early placental development: potential roles of the endometrial glands. Placenta (2007) 1.14
Effective dose from radiation absorbed during a panoramic examination with a new generation machine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 1.14
Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod (1996) 1.12
Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J Clin Endocrinol Metab (2000) 1.10
Photodestruction of pheomelanin: role of oxygen. Proc Natl Acad Sci U S A (1978) 1.10
The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstet Gynecol (1990) 1.08
Physical properties of erythrocyte ghosts that determine susceptibility to secretory phospholipase A2. J Biol Chem (2001) 1.08
Screening for cytokine messenger ribonucleic acids in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction. J Immunol (1994) 1.07
Solubilization of human platelet alpha-adrenergic receptors: evidence that agonist occupancy of the receptor stabilizes receptor--effector interactions. Proc Natl Acad Sci U S A (1981) 1.07
Scalp lacerations resulting in hemorrhagic shock: case reports and recommended management. J Emerg Med (1989) 1.07
Imprinting to chemical cues: the basis for home stream selection in salmon. Science (1976) 1.06
Transthoracic Esophagogastrostomy for Benign Strictures of the Lower Esophagus. Ann Surg (1945) 1.06
Genital oedema in patients treated by continuous ambulatory peritoneal dialysis: an unusual presentation of inguinal hernia. Br Med J (Clin Res Ed) (1983) 1.05
A role for prostacyclin (PGi2) in excessive menstrual bleeding. Lancet (1981) 1.03
AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination. Biotechniques (2001) 1.03
Incidence of hearing decline in the elderly. Acta Otolaryngol (1991) 1.02
Ca2+ dependence and pharmacology of large-conductance K+ channels in nonlabor and labor human uterine myocytes. Am J Physiol (1997) 1.02
Regulation of cyclin D2 and the cyclin D2 promoter by protein kinase A and CREB in lymphocytes. Oncogene (2006) 1.01
A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities. Oncogene (2006) 1.01
Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. Lab Invest (1997) 1.01
Glutathione-dependent antioxidant systems in the mammalian inner ear: effects of aging, ototoxic drugs and noise. Hear Res (1997) 1.01
Sodium ion modulates agonist and antagonist interactions with the human platelet alpha 2-adrenergic receptor in membrane and solubilized preparations. Mol Pharmacol (1982) 1.01
Estimating temporary populations. Appl Demor (1994) 1.01
Recurrent appendicitis. Br J Surg (1997) 1.01
Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod (2007) 1.00
Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle. J Clin Endocrinol Metab (1992) 1.00
The influence of microscopic disease at the margin of resection on recurrence rates in Crohn's disease. Ann R Coll Surg Engl (1986) 1.00
Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol (1998) 1.00